IL3 and Alzheimer disease: While half of the markers associated with diagnostic groups, 3/8 of these markers – alpha-1-antitrypsin, pancreatic polypeptide and interleukin-3 – had a median difference between AD (or MCI) and control subjects that was of the opposite sign to the partial SRC coefficient measuring their association with brain amyloid burden.